It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2009.
2009 | Chennai, Tamil Nadu, India | ActivePristine Pharma (India) Private Limited, a active private limited company, was established on 12 February 2009 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24100TN2009PTC070721. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Its leadership includes Vanmathy Venkatapathy (Director), Doraisami Rajesh (Whole-Time Director). Past directors included Santhosh Balaji Sampathkumar, Poongavanam Andappan, Sriraam Venkateswara Thirukumarasubbiah. It holds ₹1.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Old No: 11/1C, New No: 39/1C, Vannier Street, Choolaimedu, Chennai, Tamil Nadu, 600094.
U24100TN2009PTC070721
070721
12 February 2009
₹3.00 Cr
₹3.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Pristine Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vanmathy Venkatapathy | Director | 05 Dec 2012 | Current |
| Doraisami Rajesh | Whole-Time Director | 12 Feb 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 15 May 2009 | Past |
| Pramod Abcsdd | Additional Director | 12 Jul 2021 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Dec 2012 | Past |
| Pramod Abcsdd | Additional Director | 10 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pristine Pharma (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 44.46% decrease. The company also saw a slight decrease in profitability, with a 4.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Pristine Pharma (India) had a promoter holding of 48.29% and a public holding of 51.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2014 | Others | ₹7.50 M | Open |
| 06 May 2013 | The Catholic Syrian Bank Ltd | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pristine Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pristine Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pristine Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pristine Pharma (India) Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
The activity Pristine Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chennai. was completed.
A charge with Others of Rs. 0.75 Cr registered on 09 Jul 2014 with Charge ID 10518906 was modified on 17 Sep 2016. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.75 Cr with Charge ID 10518906 was registered on 09 Jul 2014. was completed.
The activity A charge with The Catholic Syrian Bank Ltd amounted to Rs. 0.40 Cr with Charge ID 10429120 was registered on 06 May 2013. was completed.
The activity Vanmathy Venkatapathy was appointed as a Director was appointed as a Director on 05 Dec 2012 & has been associated with this company since 12 years 11 months . was completed.
The CIN of Pristine Pharma (India) Private Limited is U24100TN2009PTC070721.
Pristine Pharma (India) Private Limited is headquartered at Old No: 11/1C, New No: 39/1C, Vannier Street, Choolaimedu, Chennai, Tamil Nadu, 600094.
Pristine Pharma (India) Private Limited was incorporated on 12 February 2009.
The current directors of Pristine Pharma (India) Private Limited are
The primary industry of Pristine Pharma (India) Private Limited is Manufacturing.
Pristine Pharma (India) Private Limited is unlisted.
The authorized capital of Pristine Pharma (India) Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Pristine Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX